Oracle Healthcare Acquisition (Oracle Healthcare Acquisition) EV-to-EBITDA : 0.00 (As of May. 20, 2024)

View and export this data going back to 2006. Start your Free Trial

What is Oracle Healthcare Acquisition EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Oracle Healthcare Acquisition's enterprise value is $0.00 Mil. Oracle Healthcare Acquisition's EBITDA for the trailing twelve months (TTM) ended in Dec. 2007 was $5.23 Mil. Therefore, Oracle Healthcare Acquisition's EV-to-EBITDA for today is 0.00.

The historical rank and industry rank for Oracle Healthcare Acquisition's EV-to-EBITDA or its related term are showing as below:

OHAQ's EV-to-EBITDA is not ranked ^*
in the Healthcare Providers & Services industry.
Industry Median: 12.935
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-20), Oracle Healthcare Acquisition's stock price is $0.0001. Oracle Healthcare Acquisition's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2007 was $-0.720. Therefore, Oracle Healthcare Acquisition's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.

Oracle Healthcare Acquisition EV-to-EBITDA Historical Data

The historical data trend for Oracle Healthcare Acquisition's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oracle Healthcare Acquisition EV-to-EBITDA Chart

Oracle Healthcare Acquisition Annual Data

Trend

Dec05

Dec06

Dec07

EV-to-EBITDA

33.48

33.63

Oracle Healthcare Acquisition Quarterly Data
	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07
EV-to-EBITDA	Get a 7-Day Free Trial			33.48	-	-	-	33.63

Competitive Comparison of Oracle Healthcare Acquisition's EV-to-EBITDA

For the Medical Care Facilities subindustry, Oracle Healthcare Acquisition's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oracle Healthcare Acquisition's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Oracle Healthcare Acquisition's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Oracle Healthcare Acquisition's EV-to-EBITDA falls into.

Oracle Healthcare Acquisition EV-to-EBITDA Calculation

Oracle Healthcare Acquisition's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA	=	Enterprise Value (Today)	/	EBITDA (TTM)
	=	0.000	/	5.228
	=	0.00

Oracle Healthcare Acquisition's current Enterprise Value is $0.00 Mil.
Oracle Healthcare Acquisition's EBITDA for the trailing twelve months (TTM) ended in Dec. 2007 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.23 Mil.

Oracle Healthcare Acquisition (OTCPK:OHAQ) EV-to-EBITDA Explanation

Oracle Healthcare Acquisition's PE Ratio for today is calculated as:

PE Ratio	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	0.0001	/	-0.720
	=	At Loss

Oracle Healthcare Acquisition's share price for today is $0.0001.
Oracle Healthcare Acquisition's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2007 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.720.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Oracle Healthcare Acquisition EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Oracle Healthcare Acquisition's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Oracle Healthcare Acquisition (Oracle Healthcare Acquisition) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Oracle Healthcare Acquisition Corp (OTCPK:OHAQ) » Definitions » EV-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Executives

Andrew M Weiss	10 percent owner	222 BERKELEY STREET, 16TH FLOOR, BOSTON MA 02116
Jeffrey Tannenbaum	10 percent owner	505 FIFTH AVENUE, 23RD FLOOR, NEW YORK NY 10017
Fir Tree Inc.	10 percent owner	500 FIFTH AVENUE, 9TH FLOOR, NEW YORK NY 10110
Camellia Partners, Llc	10 percent owner	51 BEDFORD ROAD, SUITES 3 & 4, KATONAH NY 10536
Andrew Fredman	10 percent owner	7301 SW 57TH COURT, SUITE 410, SOUTH MIAMI FL 33143
Fir Tree, L.l.c.	10 percent owner	505 FIFTH AVENUE, 23RD FLOOR, NEW YORK NY 10017
Per Gh Lofberg	director	C/O MERCK CAPITAL VENTURES, 50 TICE BLVD, WOODCLIFF NJ 07677
Larry N Feinberg	director, 10 percent owner	C/O ORACLE PARTNERS L P, 200 GREENWICH AVENUE, GREENWICH CT 06830
George Bickerstaff	director	C/O VION PHARMACEUTICALS, INC., 4 SCIENCE PARK, NEW HAVEN CT 06511
Kevin C Johnson	director	12 KEELERS RIDGE ROAD, WILTON CT 06897
Mark A Radzik	officer: CFO & Secretary
Joel D Liffman	director, officer: President and COO	C/O ORACLE STRATEGIES PARTNERS, L.P., 712 FIFTH AVENUE, 45TH FLOOR, NEW YORK NY 10019

Oracle Healthcare Acquisition (Oracle Healthcare Acquisition) Headlines

No Headlines